A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency)
Clinical trial NCT05876780 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05876780
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2028-08-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.